Radiation-Free Bone Health Assessment Market Report 2026

Radiation-Free Bone Health Assessment Market Report 2026 Market Overview

• Radiation-Free Bone Health Assessment Market Report 2026 market size has reached to $0.16 billion in 2025 • Expected to grow to $0.22 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Prevalence Of Osteoporosis And Osteopenia Fueling The Growth Of The Market Due To Increasing Demand For Early Bone Health Screening • Market Trend: Expansion Of Point-Of-Care Osteoporosis Screening Through Radiation-Free Technologies • Western Europe was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Radiation-Free Bone Health Assessment Market?

Radiation-free bone health assessment refers to a diagnostic approach that evaluates bone mineral density and bone quality without the use of ionizing radiation, primarily using technologies such as quantitative ultrasound (QUS) and radiofrequency echographic multi-spectrometry (REMS). These technologies enable safe, non-invasive assessment of peripheral or axial skeletal sites, supporting frequent monitoring of bone health and osteoporosis risk, particularly in children, pregnant women, and individuals requiring repeated evaluations. The main offerings of radiation-free bone health assessment include services and products. Services refer to diagnostic and assessment solutions that evaluate bone health using non-ionizing technologies to measure bone quality, density, and fracture risk without exposure to radiation. These solutions utilize technologies such as quantitative ultrasound, radiofrequency echographic multi spectrometry, and artificial intelligence enabled bone health analysis software and are performed at axial sites such as hip and spine and peripheral sites including heel, radius, tibia, and finger. They are used across different age groups such as pediatric population, adults, geriatric population, and pregnant women and are utilized by end users including hospitals and specialty clinics, primary care and diagnostic chains, public health programs, and occupational and corporate wellness programs.

What Is The Radiation-Free Bone Health Assessment Market Growth Forecast?

The radiation-free bone health assessment market size is expected to see strong growth in the next few years. It will grow to $0.22 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing adoption of portable bone assessment systems, increasing demand for radiation free diagnostic solutions, expanding public health screening initiatives, rising investment in preventive healthcare programs, increasing utilization of bone health monitoring services. Major trends in the forecast period include growing adoption of radiation free bone density screening, increasing use of portable bone health assessment devices, rising demand for frequent osteoporosis monitoring, expansion of community based bone health screening programs, growing preference for non invasive bone quality assessment.

What Is The Driver Of The Radiation-Free Bone Health Assessment Market?

The rising prevalence of osteoporosis and osteopenia is expected to propel the growth of the radiation-free bone health assessment market going forward. Rising prevalence of osteoporosis and osteopenia refers to the increasing number of people experiencing reduced bone mineral density, ranging from early-stage bone loss (osteopenia) to advanced bone weakening (osteoporosis), which increases fracture risk. The increasing prevalence of osteoporosis and osteopenia is driven by the aging population, the growing postmenopausal population, sedentary lifestyles, nutritional deficiencies, and the rising burden of chronic diseases that adversely affect bone health. As the number of individuals at risk of fractures and bone-related complications increases, the need for early detection, routine bone density monitoring, and timely preventive interventions also rises, driving greater adoption of radiation-free bone health assessment technologies. For instance, in May 2024, according to the Bone Health And Osteoporosis Foundation (BHOF), a US-based nonprofit organization, approximately 10 million Americans had osteoporosis, while an additional 44 million Americans had low bone density (osteopenia), placing them at elevated risk of fractures. Therefore, the rising prevalence of osteoporosis and osteopenia is driving the growth of the radiation-free bone health assessment industry.

Key Players In The Global Radiation-Free Bone Health Assessment Market

Major companies operating in the radiation-free bone health assessment market report are Echolight S.p.A., Esaote S.p.A., Furuno Electric Co. Ltd., OsteoSys Co. Ltd., BeamMed Ltd., Bone Index Finland Oy, CHISON Medical, SIUI (Shantou Institute of Ultrasonic Instruments Co. Ltd.), Alpinion Medical Systems Co. Ltd., Trivitron Healthcare, Vinno Technology Co. Ltd., Bone Health Screening Ltd, Precision Bone Imaging LLC, CyberLogic Inc., CompuMed Inc., Medonica Co. Ltd., POROUS GmbH

Global Radiation-Free Bone Health Assessment Market Trends and Insights

Major companies operating in the radiation-free bone health assessment market are focusing on expanding access to point-of-care osteoporosis screening through strategic partnerships and the deployment of radiation-free ultrasound technologies. Point-of-care osteoporosis screening enables rapid, non-invasive bone health assessments in community and primary care settings, facilitating early osteoporosis risk detection and timely preventive interventions. For instance, in May 2026, Bone Index Finland Oy, a Finland-based medical technology company specializing in radiation-free bone density assessment solutions, partnered with Boots, a UK-based pharmacy-led healthcare and retail company, to launch a pilot Bone Density Scan Service using Bindex ultrasound technology at selected Boots pharmacies. The initiative aimed to improve access to early osteoporosis risk assessment through radiation-free, point-of-care screening in community healthcare settings. The pilot program was designed to integrate bone health screening into routine pharmacy services, enabling individuals to undergo a quick assessment without requiring a hospital visit. The collaboration sought to support earlier identification of people at risk of low bone mineral density, allowing timely referral for further clinical evaluation when appropriate. By expanding access to convenient community-based screening, the initiative aimed to increase public awareness of osteoporosis and encourage proactive bone health management.

What Are Latest Mergers And Acquisitions In The Radiation-Free Bone Health Assessment Market?

In November 2024, Echolight S.p.A., an Italy-based medical technology company specializing in radiation-free bone densitometry solutions, partnered with Siemens Healthineers. Through this partnership, Siemens Healthineers expanded access to Echolight's REMS-based bone densitometers across the U.S., strengthening the adoption of radiation-free bone health assessment technologies. Siemens Healthineers, a Germany-based medical technology company

What Defines the Radiation-Free Bone Health Assessment Market?

The radiation-free bone health assessment market consists of revenues earned by entities providing services such as bone mineral density (BMD) screening, osteoporosis risk assessment, preventive bone health screening, bone health monitoring and follow-up, and mobile and community-based bone health screening. The market value includes the value of related goods sold by the service provider or included as part of the service offering. The radiation-free bone health assessment market also includes sales of radiation-free bone assessment devices, portable bone densitometry systems, and wireless bone assessment devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiation-Free Bone Health Assessment Market Report 2026?

The radiation-free bone health assessment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiation-free bone health assessment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.